Published in Cancer Weekly, April 6th, 1998
One of the consequences of such hormonal interferences could be the decrease in sperm count and quality recently reported in a number of countries. Indications for an increase in the incidence of some hormonally-sensitive carcinomas, including female breast cancers, as well as testicular and prostate cancers, also could be linked to the effects of these chemicals, called "endocrine disruptors."
From now on,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.